Posted by Michael Wonder on 05 Jun 2018
AstraZeneca CEO on immunotherapy, drug prices
5 June 2018 - Pascal Soriot, AstraZeneca CEO, speaks to CNBC's Meg Tirrell at ASCO conference about the company's immunotherapy treatments, research and development and his thoughts on drug pricing.
